Global trends in Nosocomial and Healthcare Acquired Infections

The global hospital acquired infections testing market is poised to grow at a compound annual growth rate (CAGR) of around 19.1% over the next decade to reach approximately $2.75 billion by 2025.

The global market for selected healthcare-acquired infection (HAI) treatments was valued at nearly $15.2 billion in 2014. This market is expected to increase from nearly $17.1 billion in 2015 to $23 billion by 2020, with a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.

Estimated cost of treating resistant infections in U.S. health care system is about $21 billion to $34 billion annually

  • Devices, Pharmaceuticals, and Environmental Products
  • Diagnostic market
  • Hand hygiene marketing in hospitals
  • Drug-Device Combinations
  • Laboratory testing tools
  • Medical devices and instruments
  • Municipal water treatment
  • Drug formulation devices
  • Molecular diagnostics

Related Conference of Global trends in Nosocomial and Healthcare Acquired Infections

Global trends in Nosocomial and Healthcare Acquired Infections Conference Speakers